Biodyne Co., Ltd.

KOSDAQ:A314930 Stock Report

Market Cap: ₩561.6b

Biodyne Balance Sheet Health

Financial Health criteria checks 6/6

Biodyne has a total shareholder equity of ₩43.1B and total debt of ₩0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₩44.4B and ₩1.2B respectively.

Key information

0%

Debt to equity ratio

₩0

Debt

Interest coverage ration/a
Cash₩20.06b
Equity₩43.14b
Total liabilities₩1.23b
Total assets₩44.37b

Recent financial health updates

Recent updates

Should You Investigate Biodyne Co., Ltd. (KOSDAQ:314930) At ₩19,100?

Oct 23
Should You Investigate Biodyne Co., Ltd. (KOSDAQ:314930) At ₩19,100?

Is There Now An Opportunity In Biodyne Co., Ltd. (KOSDAQ:314930)?

Jul 16
Is There Now An Opportunity In Biodyne Co., Ltd. (KOSDAQ:314930)?

Companies Like Biodyne (KOSDAQ:314930) Are In A Position To Invest In Growth

Jun 05
Companies Like Biodyne (KOSDAQ:314930) Are In A Position To Invest In Growth

Financial Position Analysis

Short Term Liabilities: A314930's short term assets (₩22.0B) exceed its short term liabilities (₩1.2B).

Long Term Liabilities: A314930 has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: A314930 is debt free.

Reducing Debt: A314930 has no debt compared to 5 years ago when its debt to equity ratio was 125.2%.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable A314930 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: A314930 is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 4.6% per year.


Discover healthy companies